Table 1 Demographic & clinical characteristics

Median (IQR) Age (years)

60 (51–64)

% Gender (F:M)

4:1 (79% females, 21% males)

% Ethnicity

Caucasian: 57%,

Pacific Island 14%,

Maori: 14%,

Asian: 11%,

Non-European Caucasian: 4%

Median (IQR) disease duration (years)

15 (7.3–25)

Working: (%)

34%

Not working/Beneficiary: (%)

15%

Retired: (%)

31%

Housewife/homemaker: (%)

15%

Clinical characteristics

Median (IQR) HAQ Score (0–3)

0.9 (0.4, 1.3)

% radiographic erosions

Yes: 67%; No: 33%

Pharmacological management

NSAIDS: n (%)

62 (64%)

Methotrexate: n (%)

65 (67%)

Other DMARDS: n (%)

41 (42%)

Prednisone: n (%)

32 (33%)

Biologics: n (%)

17 (17%)

Blood investigations

Median (IQR) ESR (mg/hr)

27.0 (12.0; 42.3)

Median (IQR) CRP (mm/L)

7.9 (3.8; 7.3)